                         SEQUENCE LISTING

<110>  The United States Government as Represented by the 
       Department of Veterans Affairs
 
<120>  Methods for Precision Therapeutic Targeting of Human Cancer Cell 
       Motility and Kits Thereof

<130>  37759.0083P1

<150>  US 62/628,243
<151>  2018-02-08

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  1

Glu Ile Ser Asp Asp Glu Ala Glu Glu Glu Lys Gly Glu Lys Glu Glu 
1               5                   10                  15      


Glu Asp Lys Asp Asp Glu Glu Lys Pro Lys 
            20                  25      


<210>  2
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  2

Leu Leu Lys Pro Gly Glu Glu Pro Ser Glu Tyr Thr Asp Glu Glu Asp 
1               5                   10                  15      


Thr Lys Asp His Asn Lys 
            20          


<210>  3
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  3

Asn Gly Ser Leu Asp Ser Pro Gly Lys Gln Asp Thr Glu Glu Asp Glu 
1               5                   10                  15      


Glu Glu Asp Glu Lys Asp Lys Gly Lys 
            20                  25  


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  4

Ser Arg Ser Asp Ile Asp Val Asn Ala Ala Ala Gly Ala Lys 
1               5                   10                  


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  5

Cys Asn Thr Asp Asp Thr Ile Gly Asp Leu Lys Lys 
1               5                   10          


<210>  6
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  6

Gly His His Val Thr Asp Ser Glu Asn Asp Glu Pro Leu Asn Leu Asn 
1               5                   10                  15      


Ala Ser Asp Ser Glu Ser Glu Glu Leu His Arg 
            20                  25          


<210>  7
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  7

Val Gly Pro Gly Asn His Gly Thr Glu Gly Ser Gly Gly Glu Arg His 
1               5                   10                  15      


Ser Asp Thr Asp Ser Asp Arg Arg 
            20                  


<210>  8
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  8

Val Gly Pro Gly Asn His Gly Thr Glu Gly Ser Gly Gly Glu Arg His 
1               5                   10                  15      


Ser Asp Thr Asp Ser Asp Arg Arg 
            20                  


<210>  9
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  9

Ser Glu Asp Gly Tyr His Ser Asp Gly Asp Tyr Gly Glu His Asp Tyr 
1               5                   10                  15      


Arg 
    


<210>  10
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  10

Ser Glu Ser Ser Asp Phe Glu Val Val Pro Lys 
1               5                   10      


<210>  11
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  11

Asp Arg Pro His Ala Ser Gly Thr Asp Gly Asp Glu Ser Glu Glu Asp 
1               5                   10                  15      


Pro Pro Glu His Lys Pro Ser Lys 
            20                  


<210>  12
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  12

Glu Arg Asp His Ser Pro Thr Pro Ser Val Phe Asn Ser Asp Glu Glu 
1               5                   10                  15      


Arg 
    


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  13

His Val Leu Ser Asp Leu Glu Asp Asp Glu Val Arg 
1               5                   10          


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  14

Asp Gln Lys Leu Ser Glu Leu Asp Asp Arg 
1               5                   10  


<210>  15
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  15

Asp Leu Leu Ser Asp Leu Gln Asp Ile Ser Asp Ser Glu Arg 
1               5                   10                  


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  16

Met Gln Asn Thr Asp Asp Glu Glu Arg Pro Gln Leu Ser Asp Asp Glu 
1               5                   10                  15      


Arg 
    


<210>  17
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  17

Asp Arg Pro His Ala Ser Gly Thr Asp Gly Asp Glu Ser Glu Glu Asp 
1               5                   10                  15      


Pro Pro Glu His Lys Pro Ser Lys 
            20                  


<210>  18
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  18

Thr Lys Phe Ala Ser Asp Asp Glu His Asp Glu His Asp Glu Asn Gly 
1               5                   10                  15      


Ala Thr Gly Pro Val Lys 
            20          


<210>  19
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  19

Glu Ile Ser Asp Asp Glu Ala Glu Glu Glu Lys Gly Glu Lys Glu Glu 
1               5                   10                  15      


Glu Asp Lys Asp Asp Glu Glu Lys Pro Lys 
            20                  25      


<210>  20
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  20

Ala Ala Leu Asp Ala Leu Asn Thr Asp Asp Glu Asn Asp Glu Glu Glu 
1               5                   10                  15      


Tyr Glu Ala Trp Lys 
            20      


